AI brief of an SEC Form 8-K · Lifestance Health (LFST)

LifeStance names CFO David Bourdon CEO; Ken Burdick to become Executive Chairman

Neutral Impact 4 of 5 leadership Written later

LifeStance's board promoted David Bourdon, the company's CFO since 2022, to Chief Executive Officer effective March 3, 2025, succeeding Kenneth Burdick, who is retiring as CEO and will serve as Executive Chairman. Ryan McGroarty was named Chief Financial Officer and Treasurer effective March 17, 2025, to succeed Bourdon in that role. The filing does not include financial results.

Key points

  • Bourdon becomes CEO effective March 3, 2025, with a $700,000 annual base salary and a target bonus of 100% of base salary.
  • Burdick, CEO since 2022, retires as CEO and becomes Executive Chairman with a $200,000 annual base salary.
  • McGroarty becomes CFO effective March 17, 2025, with a $550,000 base salary, a target bonus of 85% of base salary, and a $570,000 one-time signing bonus.
  • McGroarty's one-time equity award has an aggregate target grant date value of approximately $5,000,000.

The filing

CompanyLifestance Health (LFST)
Form8-K, current report
Filed with the SECFeb 27, 2025, 6:08 AM ET
Accession number0001193125-25-037533

Items reported: 5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:05 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 27, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.